Serum Collection Study for Assay Development

Recruiting now · Phase 1

Conditions studied: Pneumococcal Disease, Invasive, Pneumococcal Disease

In brief

The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation

Key facts

Study ID

NCT07205289

Run by

GPN Vaccines

People needed

12

Starts

2025-10-01

Expected to finish

2026-06-01

Last updated by the study team

2025-10-03

Who can join

Age: 18 and older, up to 69. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• good general health

You may not qualify if…

• no previous pneumococcal vaccine

Where it is running

• University of Adelaide Clinical Research Facility — Adelaide, South Australia, Australia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.